Thomas Leichner

Thomas Leichner has a diverse background in various research and analytical roles. Thomas most recently worked as an Investment Banking Analyst at Locust Walk since 2022. Prior to that, they were a Clinical Research Analyst at the University of Pennsylvania School of Medicine from 2020 to 2022. During their time there, they were involved in multiple research projects focused on imaging techniques and quantitative assessment of skeletal disorders. Thomas also worked as a Summer Analyst at CBPartners in 2021 and as a Student Research Analyst at the University of Pennsylvania in 2020. Before that, they gained experience as an Undergraduate Research Assistant at Penn Medicine, University of Pennsylvania Health System, and as a Summer Intern at the Sbarro Health Research Organization and Abington - Jefferson Health in 2019 and 2018, respectively. In these positions, they conducted various research experiments and utilized techniques such as qPCR, immunohistochemistry, and western blot analysis. Overall, Thomas Leichner has a strong foundation in research and analytical skills within both academic and industry settings.

Thomas Leichner completed their education with the following chronology:

From 2018 to 2022, they attended the University of Pennsylvania, where they obtained a Bachelor of Arts (BA) degree. Their major was Biology, and they minored in Chemistry.

Prior to attending the University of Pennsylvania, Thomas Leichner completed their high school education at Springside Chestnut Hill Academy. Thomas received their High School Diploma in 2018.

In addition to their formal education, Thomas Leichner has obtained several certifications. In July 2022, they obtained the SIE (Securities Industry Essentials) certification from FINRA and the Series 63 (Uniform Securities Agent State Law Exam) certification from NASAA. Thomas also obtained the Series 79 (Investment Banking Representative) certification from FINRA in the same month.

Furthermore, Thomas Leichner has obtained certifications in the field of Biomedical Research. In September 2021, they completed the Biomedical Research certification from the CITI Program. Thomas also obtained the Biomedical Responsible Conduct of Research certification from the same institution in the same month.